Dan-yun Ruan, Qi Dang, Suxia Luo, Yanqiu Zhao, Udit Nindra, Shou Qing Tang, Haiping Jiang, Jian Liu, Andrew Ohyama Parsonson, Michelle Frances Morris, Lin Xie, Xinjun Liang, Lilin Chen, Rui Meng, Sijuan Ding, Huaqiu Shi, Yong Fang, Meredith Pelster, Yongsheng Li, Rui-Hua Xu. "First-in-human study of ALK201, a FGFR2b-targeting antibody-drug conjugate (ADC) for patients (pts) with advanced solid tumors.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.3025